Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-15-020398
Filing Date
2015-03-02
Accepted
2015-03-02 17:47:00
Documents
2
Period of Report
2015-02-26

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1512
2 POA DOCUMENT poa.txt EX-24.3_566568 3628
  Complete submission text file 0001209191-15-020398.txt   6484
Mailing Address 7555 GATEWAY BLVD. NEWARK CA 94560
Business Address 7555 GATEWAY BLVD. NEWARK CA 94560 510-742-3400
Revance Therapeutics, Inc. (Issuer) CIK: 0001479290 (see all company filings)

EIN.: 770551645 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O REVANCE THERAPEUTICS, INC. 7555 GATEWAY BOULEVARD NEWARK CA 94560
Business Address
Vickers Philip J. (Reporting) CIK: 0001635046 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36297 | Film No.: 15666253